Massachusetts Marijuana Repeal Ballot Measure: What Voters Need to Know

Executive Summary

Massachusetts voters will decide on November 3, 2026 whether to keep or unwind the state's commercial adult-use cannabis market, and Governor Maura Healey has urged them to reject the prohibitionist ballot measure. Marijuana Moment reported her position on October 5, 2026. Her stance puts the state's top elected official against a campaign to end retail sales that voters first authorized in 2016.

The stakes are large. Massachusetts opened its first adult-use stores on November 20, 2018, and the market now generates roughly $1.5 billion or more in annual sales, according to Cannabis Control Commission (CCC) reporting. It supports thousands of jobs, hundreds of licensed businesses, and a tax stream that CannIntel estimates at around $300 million a year across state excise, sales and local taxes.

Three facts frame the vote:

• Possession and home cultivation are separate from retail. Voters decriminalized small amounts in 2008 and approved medical use in 2012. Both predate the 2016 adult-use law.
• Article 48 of the Massachusetts Constitution governs the initiative process. A successful measure needs a majority of those voting on it, and that majority must equal at least 30% of all ballots cast.
• Federal law has not changed. Marijuana remains in Schedule I under 21 U.S.C. § 812 while the DEA's rescheduling proceeding remains unresolved, so the vote is purely a question of state policy.

This page explains how Massachusetts got here, who is on each side, what the legal mechanics are, and what a "yes" or "no" result would mean for operators, patients, neighboring states and investors. CannIntel will append dated updates as polling, campaign finance filings and regulatory guidance arrive.

Why This Matters

A repeal in Massachusetts would be the first time voters rolled back a legal adult-use retail market, and it would test whether legalization is politically irreversible. CannIntel is not aware of any state that has repealed adult-use legalization by statewide vote after launching sales. That makes the outcome a national signal as well as a local one.

Stakeholders

• Licensed operators. Cultivators, manufacturers, retailers, delivery companies and testing labs hold CCC licenses. Multi-state operators (MSOs) including Curaleaf, Verano and Ascend Wellness Holdings have Massachusetts footprints. The state also has many independent owners and social equity and economic empowerment licensees.
• Patients. The medical program under M.G.L. c. 94I serves registered patients, many of whom now buy at adult-use stores. The treatment of medical access in the repeal text should be confirmed against the official ballot language.
• Municipalities. Cities and towns collect up to a 3% local tax and negotiate host community agreements. Many budgets now depend on that revenue.
• Consumers and neighbors. New Hampshire residents cross the border to buy, and Rhode Island, Connecticut and New York have launched their own markets.

The dollars

Massachusetts layers a 10.75% state excise tax, the 6.25% state sales tax and a local option of up to 3%. CannIntel's back-of-envelope math at $1.6 billion in annual sales produces about $172 million in excise, $100 million in sales tax and $48 million in local tax, or roughly $320 million combined. That is a CannIntel estimate, not a CCC figure. Operators and municipalities should model their own exposure from actual filings.

The policy stakes

The proponents of repeal argue that commercialization has normalized high-potency products and heavier use. Opponents of repeal argue that prohibition would hand sales back to an unregulated market with no testing, no age-gating and no tax revenue. Both claims rest on contested evidence, and voters will decide between them.

Background and History

Massachusetts moved from civil decriminalization in 2008 to medical access in 2012 to full adult-use commerce in 2018, with voters approving each step at the ballot box. The 2026 measure is the first to ask voters to reverse course.

2008: Question 2 decriminalizes possession

Voters approved Question 2 in 2008 with roughly 65% support. It replaced criminal penalties for possessing up to one ounce with a civil fine of $100 (M.G.L. c. 94C, § 32L). The vote established early that Massachusetts voters were willing to override legislative caution on cannabis through the initiative process.

2012: Question 3 creates the medical program

Question 3 passed in 2012 with about 63%. It created a state-regulated medical marijuana system with nonprofit dispensaries, then called registered marijuana dispensaries. The first dispensary opened in 2015. The system was slow to start and tightly controlled, but it built the patient base and cultivation expertise that fed the later adult-use market.

2016: Question 4 legalizes adult use

Question 4, "The Regulation and Taxation of Marijuana Act," passed on November 8, 2016 with about 54% of the vote. It allowed adults 21 and older to possess up to one ounce in public and ten ounces at home and to grow up to six plants per person, with a 12-plant household cap. It also set up commercial licensing.

The 2016 campaign was bipartisan in opposition. Then-Governor Charlie Baker, Boston Mayor Marty Walsh and then-Attorney General Maura Healey all opposed the measure, as did the Massachusetts Medical Society. The Marijuana Policy Project (MPP) backed the winning side.

2017: Legislature rewrites the law

Lawmakers delayed implementation and rewrote parts of the initiative in Chapter 55 of the Acts of 2017. The changes raised the tax structure, gave municipalities more control and created the independent Cannabis Control Commission. The initiative's core, legal possession and regulated sale, survived. The codified framework now sits largely in M.G.L. c. 94G.

2018: Retail sales begin

Cultivate in Leicester and New England Treatment Access in Northampton opened their doors on November 20, 2018. Rollout was slow for years because many municipalities banned or delayed stores, and